These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36149818)

  • 1. The correlation between maternal serum sST2, IL-33 and NT-proBNP concentrations and occurrence of pre-eclampsia in twin pregnancies: A longitudinal study.
    Xiang Q; Chen Y; Gu X; Yang Y; Wang Y; Zhao Y
    J Clin Hypertens (Greenwich); 2022 Nov; 24(11):1516-1523. PubMed ID: 36149818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of N-terminal fragment of precursor protein brain-type natriuretic peptide (NT-proBNP) in twin pregnancy.
    Yamada T; Koyama T; Furuta I; Takeda M; Nishida R; Yamada T; Morikawa M; Minakami H
    Clin Chim Acta; 2013 Jan; 415():41-4. PubMed ID: 22959924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revised competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal characteristics and medical history.
    Benkő Z; Chaveeva P; de Paco Matallana C; Zingler E; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):617-624. PubMed ID: 31364214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of N-terminal pro-B natriuretic peptide to soluble fms-like tyrosine kinase-1/placental growth factor ratio > 38 improves prediction of pre-eclampsia requiring delivery within 1 week: a longitudinal cohort study.
    Sabriá E; Lequerica-Fernández P; Lafuente-Ganuza P; Eguia-Ángeles E; Escudero AI; Martínez-Morillo E; Barceló C; Álvarez FV
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):758-767. PubMed ID: 29498431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of chronic heart failure by the soluble suppression of tumorigenicity 2 and N-terminal pro-brain natriuretic peptide.
    Jin XL; Huang N; Shang H; Zhou MC; Hong Y; Cai WZ; Huang J
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28719009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Not Available].
    Protasov VN; Narusov OY; Skvortsov AA; Protasova DE; Kuznetsova TV; Petrukhina AA; Masenko VP; Tereshchenko SN
    Kardiologiia; 2019 Jan; 59(1S):53-64. PubMed ID: 30706839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior prognostic value of soluble suppression of tumorigenicity 2 for the short-term mortality of maintenance hemodialysis patients compared with NT-proBNP: a prospective cohort study.
    Wang Z; Chen Z; Yu H; Ma X; Zhang C; Qu B; Zhang W; Chen X
    Ren Fail; 2020 Nov; 42(1):523-530. PubMed ID: 32460670
    [No Abstract]   [Full Text] [Related]  

  • 8. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11-13 weeks' gestation: data from EVENTS trial.
    Benkő Z; Wright A; Rehal A; Cimpoca B; Syngelaki A; Delgado JL; Tsokaki T; De Alvarado M; Vojtassakova D; Malligiannis Ntalianis K; Chaveeva P; Del Campo A; De Ganzo T; Resta C; Atanasova V; Accurti V; Villalain C; Aguilera J; Dojcinovska D; O'Gorman N; Plasencia W; Zingler E; Dutemeyer V; Alvar B; Casanova MC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):257-265. PubMed ID: 33142361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Levels of N-Terminal Pro-Brain Natriuretic Peptide in Gestational Hypertension, Mild Preeclampsia, and Severe Preeclampsia: A Study from a Center in Zhejiang Province, China.
    Zheng Z; Lin X; Cheng X
    Med Sci Monit; 2022 Mar; 28():e934285. PubMed ID: 35228509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial establishment and validation of a predictive model for preeclampsia in twin pregnancies based on maternal characteristics and echocardiographic parameters.
    Xiang Q; Wei Y; Feng X; Chen S; Zhao Y
    Acta Obstet Gynecol Scand; 2023 Nov; 102(11):1566-1574. PubMed ID: 37533238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competing-risks model in screening for pre-eclampsia in twin pregnancy by maternal characteristics and medical history.
    Francisco C; Wright D; Benkő Z; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):501-506. PubMed ID: 28508528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation].
    Skvortsov AA; Protasov VN; Narusov OY; Koshkina DE; Nasonova SN; Masenko VP; Tereschenko SN
    Kardiologiia; 2017 Jan; (1):48-58. PubMed ID: 28290833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Preeclampsia in Nulliparous Women according to First Trimester Maternal Factors and Serum Markers.
    Pihl K; Sørensen S; Stener Jørgensen F
    Fetal Diagn Ther; 2020; 47(4):277-283. PubMed ID: 31622970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of combined sST2 and NT-proBNP detection for the short-term prognosis of acute organophosphorus pesticide poisoning].
    Chen J; Zhu J; Liu XT; Wang L; Qi HN; Ma GY
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Sep; 39(9):671-674. PubMed ID: 34624949
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnostic value of combining serum soluble ST2 and interleukin-33 for heart failure patients with preserved left ventricular ejection fraction].
    Luo NS; Zhang HF; Liu PM; Lin YQ; Huang TC; Yang Y; Wang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):198-203. PubMed ID: 28316175
    [No Abstract]   [Full Text] [Related]  

  • 16. A more accurate prediction to rule in and rule out pre-eclampsia using the sFlt-1/PlGF ratio and NT-proBNP as biomarkers.
    Lafuente-Ganuza P; Lequerica-Fernandez P; Carretero F; Escudero AI; Martinez-Morillo E; Sabria E; Herraiz I; Galindo A; Lopez A; Martinez-Triguero ML; Alvarez FV
    Clin Chem Lab Med; 2020 Feb; 58(3):399-407. PubMed ID: 31734648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphofunctional cardiac changes in singleton and twin pregnancies: a longitudinal cohort study.
    Umazume T; Yamada T; Furuta I; Iwano H; Morikawa M; Watari H; Minakami H
    BMC Pregnancy Childbirth; 2020 Dec; 20(1):750. PubMed ID: 33267789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early second-trimester plasma levels of NT-proBNP in women who subsequently develop early-onset preeclampsia.
    Junus K; Wikström AK; Larsson A; Olovsson M
    J Matern Fetal Neonatal Med; 2017 Sep; 30(18):2163-2165. PubMed ID: 27677676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation.
    Francisco C; Wright D; Benkő Z; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):589-595. PubMed ID: 28556556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.